Timeline: The program is scheduled to end after Dec
The compounds favorable safety profile, selective mechanism, and research-backed efficacy make it an attractive option for individuals seeking to optimize body composition, enhance metabolic health, and support healthy aging processes
It should not be used by people with hereditary metabolic diseases or kidney diseases without consulting a doctor
While leflunomide has been shown to be effective in treating RA, its use is accompanied by certain limitations and potential adverse effects, including diarrhea, nausea, alopecia, and hepatotoxicity, as reported in previous studies (205, 206)
While these symptoms typically improve over time, they can be challenging for some patients to tolerate, particularly during the initial stages of treatment
Eden offers these